Results 21 to 30 of about 9,301 (216)

Levels of von Willebrand factor antigen and von Willebrand factor cleaving protease (ADAMTS13) activity predict clinical events in chronic heart failure. [PDF]

open access: yes, 2009
Decreased activity of ADAMTS13, the von Willebrand factor (VWF) cleaving protease, was recently reported in cardiovascular diseases and in hepatic failure.
Borgulya, Gábor   +10 more
core   +1 more source

ADAMTS13 activity and inhibitor [PDF]

open access: yesAmerican Journal of Hematology, 2008
AbstractThrombotic thrombocytopenic purpura (TTP) is often associated with acquired or congenital deficiency of the von Willebrand factor‐cleaving metalloprotease, ADMATS13 (Lammle B et al., J Thromb Haemost 2005;3:1663‐1675; Schneppenheim et al., Blood 2003;101:1845‐1850).
Adriana, Doldan-Silvero   +4 more
openaire   +2 more sources

A phenotype–genotype correlation of ADAMTS13 mutations in congenital thrombotic thrombocytopenic purpura patients treated in the United Kingdom [PDF]

open access: yes, 2012
Background:  ADAMTS13 mutations play a role in thrombotic thrombocytopenic purpura (TTP) pathogenesis. Objectives:  To establish a phenotype–genotype correlation in a cohort of congenital TTP patients.
Machin, S.J.   +7 more
core   +1 more source

ADAMTS13 activity in sickle cell disease [PDF]

open access: yes, 2006
Sickle red blood cell (SRBC)-endothelial adhesion plays a central role in sickle cell disease (SCD)-related vaso-occlusion. As unusually large von Willebrand factor (ULVWF) multimers mediate SRBC-endothelial adhesion, we investigated the activity of ...
Krieg, S   +9 more
core   +1 more source

Association between ADAMTS13 deficiency and cardiovascular events in chronic hemodialysis patients

open access: yesScientific Reports, 2021
A mild decrease of ADAMTS13 (a disintegrin and metalloprotease with thrombospodin type 1 motif 13) could attribute to stroke and coronary heart disease in general population.
Shih-Yuan Hung   +9 more
doaj   +1 more source

Mechanism of ADAMTS13 regulation [PDF]

open access: yes, 2022
Studies demonstrated ADAMTS13 possesses unique properties with a mystifying regulatory mechanism. ADAMTS13’s role is in its proteolytic function to its VWF.
Madarati, Hasam
core  

ADAMTS13 and microvascular thrombosis [PDF]

open access: yesExpert Review of Cardiovascular Therapy, 2006
Interaction between platelet and von Willebrand factor, a circulating adhesive glycoprotein, is essential for hemostasis under the high shear environments of arterioles and capillaries. If unregulated, this interaction may lead to unwarranted platelet thrombosis.
openaire   +2 more sources

Mechanistic Studies on ADAMTS13 Catalysis [PDF]

open access: yesBiophysical Journal, 2008
The zinc-protease a disintegrin-like and metalloprotease with thrombospondin type I repeats (ADAMTS13) cleaves the Tyr(1605)-Met(1606) peptide bond of von Willebrand factor (VWF), avoiding the accumulation of ultra large VWF multimers. Hydrolysis by ADAMTS13 of a VWF analog (Asp(1596)-Arg(1668) peptide, fluorescence energy transfer substrate [FRETS ...
Di Stasio, Enrico   +5 more
openaire   +4 more sources

Role of ADAMTS13 in the pathogenesis, diagnosis, and treatment of thrombotic thrombocytopenic purpura [PDF]

open access: yes, 2012
The regulation of VWF multimer size is essential in preventing spontaneous microvascular platelet clumping, a central pathophysiologic finding in thrombotic thrombocytopenic purpura (TTP).
Kremer Hovinga, Johanna A   +1 more
core   +1 more source

vWF/ADAMTS13 is associated with on-aspirin residual platelet reactivity and clinical outcome in patients with stable coronary artery disease

open access: yesThrombosis Journal, 2017
Background The mechanisms behind residual platelet reactivity (RPR) despite aspirin treatment are not established. It has been shown that coronary artery disease (CAD) patients with high on-aspirin RPR have elevated levels of von Willebrand factor (vWF).
Ellen M. K. Warlo   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy